Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Valsartan to Prevent Left Ventricle Remodeling in Pacemaker Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified August 2015 by Medical University of Silesia
Sponsor:
Collaborator:
Polpharma Pharmaceutical Company
Information provided by (Responsible Party):
Andrzej Tomasik MD PhD FESC, Medical University of Silesia
ClinicalTrials.gov Identifier:
NCT01805804
First received: March 2, 2013
Last updated: August 17, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):